Sr. S V VeeramaniPresidente y Director GerenteFourrts (India) Laboratories Pvt Ltd (Chennai)PERFILFundador y Presidente de Fourrts (India) Laboratorios Pvt Limited, una compañía farmacéutica creciendo rápidamente, basada en Chennai, el Sr. Veeramani tiene más de 30 años de la experiencia exitosa en la industria farmacéutica. Fourrts ha ganado el Premio de la Excelencia de la Calidad
Today, pharmaceutical, biotechnology and life sciences sectors have emerged as the new hot favourite with the service industry and logistics companies are rushing in to offer tailor-made solutions.
India's fast-growing economy, expansion in health care insurance and infrastructure, to grow national drug sales to $20 billion by 2015
New Media Communication Private LimitedHEAD OFFICE Prajwala Poojary Corporate CommunicationNew Media Communication Pvt Ltd1 Akbar Villa, Marol-Maroshi Road,Andheri (E), Mumbai – 400059 India.Phone: +91 22 29250690/29202999Website: www.newmediacomm.comE-mail: firstname.lastname@example.org Branches PuneJadish Khaladkar Regional DirectorSahyog Apartment, 508, Narayan Peth,Patrya Maruti Chowk, Pune- 411 030Tel/fax: 91-020-24454642 / 24451574Moblie: 09823038315 Email: email@example.com ; firstname.lastname@example.org KolkataAnurag Sinha Branch ManagerA-7/1, Satyam Park,2nd lane, Near 3A Bus Stand,Thakurpukur,
Hoy, India es reconocida como uno de los participantes dirigentes globales en productos farmacéuticos. Manejado por las habilidades del conocimiento, las empresas crecientes, los costos bajos, la calidad mejorada y la demanda alcista (ambos doméstico e internacional), el valor del sector farmacéutico de la producción creció más que diez veces de US $1,1 mil millones en 1990 a más de US $ 12,4 mil millones durante 2005-06.
Aujourd'hui, l'Inde est reconnue comme un des principaux acteurs globaux en pharmaceutiques. Dirigé par les la connaissance, les entreprises croissantes, les bas coûts, la qualité améliorée et la demande soutenue (domestique et international), le rendement du secteur pharmaceutique a accru plus que dix fois de US$ 1,1 milliard en 1990 à plus de US$ 12,4 milliards pendant 2005-06.
Alliance Boots will enter the Indian retail market in the food, health and personal care (FHPC) format, with an obvious focus on the pharma segment.
Subhiksha, 98.4 Degrees, Guardian Lifecare and Med Plus plan to invest around Rs 600 crore over the next two years.
Centre plans to introduce stringent norms to curb the practice of engaging unqualified staff at the pharmacy counters to dispense drugs is welcomed
Indian pharmaceutical machines are gaining more and more acceptance in International market. The companies are exploring advanced markets like US and Europe for their machinery.
Spurious drugs problem are general, infrastructural and legal and measures are need to be tackled them at each level.
India's spurious drug industry sells 35 percent of its produce worldwide. The problem of spurious and substandard drugs in the country is quite unbridled
Central and State authorities will have understand and find solutions to the problems and difficulties faced by regulators who check illegal activity of manufacture and trading in spurious and substandard drugs which poses a major threat to public health in India
According to new report, published by the Freedonia Group, the world wide demand for pharmaceutical packaging is set to rise to 5.9 % annually to over $34 billion in 2011 and $45billion by 2016
Packaging firms are attracted to the lower-wage countries such as India and China having an eager and plentiful workforce. Worldwide drug packaging is expected to reach new heights, predicting growth of 5.3 per cent annually to $24.3 billion (€20 7 billion) in 2009 according to the new report published by Freedonia group.
Today, India is recognized as one of the leading global players in pharmaceuticals. Driven by the knowledge skills, growing enterprises, low costs, improved quality and buoyant demand (both domestic and international), the pharmaceutical sector's value of output grew more than tenfold from US$ 1.1 billion in 1990 to over US$ 12.4 billion during 2005-06.
AstraZeneca PLC announced that on June 18, 2007 it has completed its acquisition of MedImmune, Inc. pursuant to a short-form merger in which a subsidiary of AstraZeneca was merged with and into MedImmune with MedImmune continuing as the surviving corporation.
International organizations and FDA plays important role in checking improving the quality of medicines in World Pharmaceutical market.
FDA play important role as they ensure that food is safe and wholesome, cosmetics won't hurt people, the medicines and medical devices are safe and effective, and that radiation-emitting products such as microwave ovens won't do harm. Feed and drugs for pets and farm animals also come under FDA scrutiny.
Nanotechnology holds great promise for the development of new treatments and diagnostics. Nanotechnology may provide new drugs that are able to reach specific areas of the body more effectively and at safer doses.